STATE STREET CORP - TCR2 THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$205,829
-5.7%
137,219
-37.2%
0.00%
Q4 2022$218,376
+10.9%
218,638
+100.0%
0.00%
Q3 2022$197,000
-37.9%
109,3190.0%0.00%
Q2 2022$317,000
-78.0%
109,319
-79.1%
0.00%
Q1 2022$1,444,000
-39.9%
523,157
+1.5%
0.00%
Q4 2021$2,401,000
-81.4%
515,189
-66.0%
0.00%
-100.0%
Q3 2021$12,890,000
-64.8%
1,514,717
-32.1%
0.00%
-50.0%
Q2 2021$36,614,000
-24.2%
2,231,224
+2.0%
0.00%
-33.3%
Q1 2021$48,319,000
+59.9%
2,188,354
+124.0%
0.00%
+50.0%
Q4 2020$30,220,000
+316.0%
977,060
+173.3%
0.00%
Q3 2020$7,264,000
+82.8%
357,463
+38.2%
0.00%
Q2 2020$3,973,000
+152.7%
258,683
+27.3%
0.00%
Q1 2020$1,572,000
-45.9%
203,155
-0.1%
0.00%
Q4 2019$2,904,000
+15.9%
203,352
+22.0%
0.00%
Q3 2019$2,505,000
+1548.0%
166,634
+1033.6%
0.00%
Q2 2019$152,00014,7000.00%
Other shareholders

There were no reported owners of TCR2 THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TCR2 THERAPEUTICS INC shareholders